{"id":60005,"date":"2026-06-04T22:55:26","date_gmt":"2026-06-04T13:55:26","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4883\/"},"modified":"2026-09-27T15:51:43","modified_gmt":"2026-09-27T06:51:43","slug":"company-4883","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4883\/","title":{"rendered":"MODALIS THERAPEUTICS CORP"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4883","DATE":"2026-01-09","longName":"Modalis Therapeutics Corporation","company_name_ja":"","fullTimeEmployees":17,"address":"","phone":"","website":"https:\/\/modalistx.com","industry":"Drug Manufacturers - Specialty & Generic","sector":"Healthcare","regularMarketPrice":61,"financialCurrency":"","marketCap":4692,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":-27.859999999999999,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":-2211800000,"operatingMargins":0,"NetIncome":-2152710000,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":-77.069999999999993,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-09-01T04:58:20.070741\", \"ticker\": \"4883\", \"ticker_full\": \"4883.T\", \"company_name\": \"MODALIS THERAPEUTICS CORP\", \"analyst_recommendations\": {\"has_data\": true, \"recommendation_key\": \"none\", \"recommendation_mean\": null, \"total_analysts\": null, \"strong_buy\": null, \"buy\": null, \"hold\": null, \"sell\": null, \"strong_sell\": null}, \"target_prices\": {\"has_data\": true, \"current\": 35.0, \"high\": null, \"low\": null, \"mean\": null, \"median\": null}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": null, \"future_count\": 0, \"past_earnings\": [{\"date\": \"2023-11-06\", \"eps_estimate\": -14.5, \"eps_actual\": -17.59, \"surprise_pct\": -21.31}, {\"date\": \"2023-08-06\", \"eps_estimate\": -10.07, \"eps_actual\": -16.84, \"surprise_pct\": -67.23}, {\"date\": \"2023-02-12\", \"eps_estimate\": 12.36, \"eps_actual\": -47.81, \"surprise_pct\": -486.81}, {\"date\": \"2022-11-07\", \"eps_estimate\": -17.21, \"eps_actual\": -18.34, \"surprise_pct\": -6.57}, {\"date\": \"2022-08-04\", \"eps_estimate\": -10.01, \"eps_actual\": -11.57, \"surprise_pct\": -15.58}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 8.91, \"institution_pct\": 3.96, \"major_holders\": [{\"label\": \"\", \"value\": 8.91}, {\"label\": \"\", \"value\": 3.96}, {\"label\": \"\", \"value\": 4.34}, {\"label\": \"\", \"value\": 3.0}], \"institutional_holders\": [], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. The company is developing therapies for genetic diseases using its proprietary CRISPR-GNDM an epigenome editing technology that combines dCas9. It also develops various therapeutics for muscle disorders, cardiomyopathy, and CNS disorders. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was incorporated in 2016 and is headquartered in Chuo, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-09-27T04:53:12.105548\", \"ticker\": \"4883\", \"ticker_full\": \"4883.T\", \"company_name\": \"MODALIS THERAPEUTICS CORP\", \"company_info\": {\"name_en\": \"MODALIS THERAPEUTICS CORP\", \"long_name\": \"Modalis Therapeutics Corporation\", \"sector\": \"Healthcare\", \"industry\": \"Drug Manufacturers - Specialty & Generic\", \"website\": \"https:\/\/modalistx.com\", \"employees\": 17, \"country\": \"Japan\", \"city\": \"Chuo\", \"address\": \"Nihonbashi-Lifescience-Bldg.2\", \"description\": \"Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. The company is developing therapies for genetic diseases using its proprietary CRISPR-GNDM an epigenome editing technology that combines dCas9. It also develops various therapeutics for muscle disorders, cardiomyopathy, and CNS disorders. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was incorporated in 2016 and is headquartered in Chuo, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 33.0, \"deviation\": 0.0, \"trend\": \"down\"}, \"ma_25\": {\"ma_value\": 34.12, \"deviation\": -3.28, \"trend\": \"down\"}, \"ma_75\": {\"ma_value\": 33.29, \"deviation\": -0.88, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 48.84, \"deviation\": -32.44, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -2211800000.0, \"operating_income_fmt\": \"-\u00a522\u5104\", \"ebit\": -2148366000.0, \"ebit_fmt\": \"-\u00a521\u5104\", \"net_income\": -2152710000.0, \"net_income_fmt\": \"-\u00a522\u5104\", \"eps\": -27.86, \"operating_margin\": 0, \"total_assets\": 2964248000.0, \"total_assets_fmt\": \"\u00a530\u5104\", \"total_equity\": 2793304000.0, \"total_equity_fmt\": \"\u00a528\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 2812367000.0, \"total_cash_fmt\": \"\u00a528\u5104\", \"equity_ratio\": 94.23, \"de_ratio\": 0.0, \"current_ratio\": 21.46, \"operating_cf\": -2118409000.0, \"operating_cf_fmt\": \"-\u00a521\u5104\", \"investing_cf\": -2571000.0, \"investing_cf_fmt\": \"-\u00a52.6M\", \"financing_cf\": 1351037000.0, \"financing_cf_fmt\": \"\u00a514\u5104\", \"free_cf\": -2120980000.0, \"free_cf_fmt\": \"-\u00a521\u5104\", \"net_margin\": 0, \"roe\": -77.07, \"roa\": -72.62}, {\"year\": 2024, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -1337650000.0, \"operating_income_fmt\": \"-\u00a513\u5104\", \"ebit\": -1313072000.0, \"ebit_fmt\": \"-\u00a513\u5104\", \"net_income\": -1317894000.0, \"net_income_fmt\": \"-\u00a513\u5104\", \"eps\": -28.57, \"operating_margin\": 0, \"total_assets\": 3691549000.0, \"total_assets_fmt\": \"\u00a537\u5104\", \"total_equity\": 3548077000.0, \"total_equity_fmt\": \"\u00a535\u5104\", \"total_debt\": 0.0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 3575277000.0, \"total_cash_fmt\": \"\u00a536\u5104\", \"equity_ratio\": 96.11, \"de_ratio\": 0.0, \"current_ratio\": 30.83, \"operating_cf\": -1432005000.0, \"operating_cf_fmt\": \"-\u00a514\u5104\", \"investing_cf\": -188000.0, \"investing_cf_fmt\": \"-\u00a5188,000\", \"financing_cf\": 3044985000.0, \"financing_cf_fmt\": \"\u00a530\u5104\", \"free_cf\": -1432193000.0, \"free_cf_fmt\": \"-\u00a514\u5104\", \"net_margin\": 0, \"roe\": -37.14, \"roa\": -35.7}, {\"year\": 2023, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -2370665000.0, \"operating_income_fmt\": \"-\u00a524\u5104\", \"ebit\": -2386193000.0, \"ebit_fmt\": \"-\u00a524\u5104\", \"net_income\": -2391821000.0, \"net_income_fmt\": \"-\u00a524\u5104\", \"eps\": -77.24, \"operating_margin\": 0, \"total_assets\": 2025925000.0, \"total_assets_fmt\": \"\u00a520\u5104\", \"total_equity\": 1380422000.0, \"total_equity_fmt\": \"\u00a514\u5104\", \"total_debt\": 412500000.0, \"total_debt_fmt\": \"\u00a54\u5104\", \"total_cash\": 1883437000.0, \"total_cash_fmt\": \"\u00a519\u5104\", \"equity_ratio\": 68.14, \"de_ratio\": 0.3, \"current_ratio\": 9.88, \"operating_cf\": -2254466000.0, \"operating_cf_fmt\": \"-\u00a523\u5104\", \"investing_cf\": -39699000.0, \"investing_cf_fmt\": \"-\u00a539.7M\", \"financing_cf\": 1216451000.0, \"financing_cf_fmt\": \"\u00a512\u5104\", \"free_cf\": -2294165000.0, \"free_cf_fmt\": \"-\u00a523\u5104\", \"net_margin\": 0, \"roe\": -173.27, \"roa\": -118.06}, {\"year\": 2022, \"revenue\": 40500000.0, \"revenue_fmt\": \"\u00a540.5M\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -2063194000.0, \"operating_income_fmt\": \"-\u00a521\u5104\", \"ebit\": -2702208000.0, \"ebit_fmt\": \"-\u00a527\u5104\", \"net_income\": -2702709000.0, \"net_income_fmt\": \"-\u00a527\u5104\", \"eps\": -92.85, \"operating_margin\": -5094.31, \"total_assets\": 3129833000.0, \"total_assets_fmt\": \"\u00a531\u5104\", \"total_equity\": 2941232000.0, \"total_equity_fmt\": \"\u00a529\u5104\", \"total_debt\": 0.0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 2933162000.0, \"total_cash_fmt\": \"\u00a529\u5104\", \"equity_ratio\": 93.97, \"de_ratio\": 0.0, \"current_ratio\": 21.58, \"operating_cf\": -1895773000.0, \"operating_cf_fmt\": \"-\u00a519\u5104\", \"investing_cf\": -185719000.0, \"investing_cf_fmt\": \"-\u00a52\u5104\", \"financing_cf\": 63683000.0, \"financing_cf_fmt\": \"\u00a563.7M\", \"free_cf\": -2093060000.0, \"free_cf_fmt\": \"-\u00a521\u5104\", \"net_margin\": -6673.36, \"roe\": -91.89, \"roa\": -86.35}, {\"year\": 2021, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": 0, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-60005","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MODALIS THERAPEUTICS CORP - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4883\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4883\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4883\/\",\"name\":\"MODALIS THERAPEUTICS CORP - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T13:55:26+00:00\",\"dateModified\":\"2026-09-27T06:51:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4883\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4883\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4883\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MODALIS THERAPEUTICS CORP\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MODALIS THERAPEUTICS CORP - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4883\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4883\/","url":"https:\/\/japanir.jp\/en\/company\/company-4883\/","name":"MODALIS THERAPEUTICS CORP - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T13:55:26+00:00","dateModified":"2026-09-27T06:51:43+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4883\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4883\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4883\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"MODALIS THERAPEUTICS CORP"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/60005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=60005"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=60005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}